Hopfner Robert Lorne

Hopfner Robert Lorne is listed in filings as Director at Rallybio Corporation. This profile follows SEC Form 4 activity through Jul 3, 2025, including 4 public disclosures. Recent filings connect the profile to Rallybio Corporation (RLYB) and Inozyme Pharma, Inc. (INZY). The current snapshot covers public activity from Jun 20, 2024 to Jul 3, 2025. Reported amounts are shown as $69.9K to $123.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.